Melatonin improves insulin sensitivity independently of weight loss in old obese rats

Journal of Pineal Research

Volumn 55, Issue 2, 2013, Pages 156-165

  Zanuto, Ricardo ^a   Siqueira Filho, Mário A ^a   Caperuto, Luciana C ^b   Bacurau, Reury F P ^a   Hirata, Emiko ^b   Peliciari Garcia, Rodrigo A ^a   Do Amaral, Fernanda Gaspar ^a   Marcal, Anderson C ^a   Ribeiro, Luciene M ^a   Camporez, Joao P G ^a   Carpinelli, Angelo Rafael ^a   Bordin, Silvana ^a   Cipolla Neto, Jose ^a   Carvalho, Carla R O ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Aging; Insulin; Insulin signaling pathway; Melatonin; Obesity

Indexed keywords

GLUCOSE; INSULIN; INSULIN RECEPTOR SUBSTRATE 1; INSULIN RECEPTOR SUBSTRATE 2; MELATONIN; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; ANTIOXIDANT;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY MASS; BODY WEIGHT; CONTROLLED STUDY; FLUID INTAKE; FOOD INTAKE; GLUCOSE BLOOD LEVEL; HORMONE SYNTHESIS; HYPOTHALAMUS; IMMUNOBLOTTING; IMMUNOPRECIPITATION; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIVER; MALE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; WEIGHT REDUCTION; AGING; ANIMAL; DIET SUPPLEMENTATION; DRUG SCREENING; GLUCOSE METABOLISM DISORDERS; METABOLISM; OBESITY; RANDOMIZATION; WISTAR RAT;

AGING; ANIMALS; ANTIOXIDANTS; DIETARY SUPPLEMENTS; DRUG EVALUATION, PRECLINICAL; GLUCOSE METABOLISM DISORDERS; INSULIN RESISTANCE; MALE; MELATONIN; OBESITY; RANDOM ALLOCATION; RATS; RATS, WISTAR;

EID: 84885186506     PISSN: 07423098     EISSN: 1600079X     Source Type: Journal    
DOI: 10.1111/jpi.12056     Document Type: Article

References (71)

1. BJORNTORP P. Neuroendocrine ageing. J Intern Med 1995; 238:401-404.
2. CHAMNAN P, SIMMONS RK, SHARP SJ et al. Cardiovascular risk assessment scores for people with diabetes: a systematic review. Diabetologia 2009; 52:2001-2014.
3. CHENG AYY, LEITER LA. Cardiovascular risk and glycemic control. CMAJ 2009; 180:907-908.
4. CARVALHO CR, BRENELLI SL, SILVA AC et al. Effect of aging on insulin receptor, insulin receptor substrate-1, and phosphatidylinositol 3-kinase in liver and muscle of rats. Endocrinology 1996; 137:151-159.
5. CARVALHO CR, MAEDA L, BRENELLI SL et al. Tissue-specific regulation of IRS-2/PI 3-kinase association in aged rats. Biol Chem 2000; 381:75-78.
6. AHIMA RS, FLIER JS. Adipose tissue as an endocrine organ. Trends Endocrinol Metab 2000; 11:327-332.
7. FRUHBECK G, GOMEZ-AMBROSI J, MURUZABAL FJ et al. The adipocyte: a model for integration of endocrine and metabolic signaling in energy metabolism regulation. Am J Physiol Endocrinol Metab 2001; 280:E827-847.
8. FERNANDES ML, SAAD MJ, VELLOSO LA. Effects of age on elements of insulin-signaling pathway in central nervous system of rats. Endocrine 2001; 16:227-234.
9. PANG SF, TSANG CW, HONG GX et al. Fluctuation of blood melatonin concentrations with age: result of changes in pineal melatonin secretion, body growth, and aging. J Pineal Res 1990; 8:179-192.
10. REITER RJ. The ageing pineal gland and its physiological consequences. BioEssays 1992; 14:169-175.
11. KARASEK M. Melatonin, human aging, and age-related diseases. Exp Gerontol 2004; 39:1723-1729.
12. SANCHEZ-HIDALGO M, de la LASTRA CA, CARRASCOSA-SALMORAL MP et al. Age-related changes in melatonin synthesis in rat extrapineal tissues. Exp Gerontol 2009; 44:328-334.
13. KREIER F, KALSBEEK A, SAUERWEIN HP et al. "Diabetes of the elderly" and type 2 diabetes in younger patients: possible role of the biological clock. Exp Gerontol 2007; 42:22-27.
14. STEHLE JH, SAADE A, RAWASHDEH O et al. A survey of molecular details in the human pineal gland in the light of phylogeny, structure, function and chronobiological diseases. J Pineal Res 2011; 51:17-43.
15. GRAD BR, ROZENCWAIG R. The role of melatonin and serotonin in aging: update. Psychoneuroendocrinology 1993; 18:283-295.
16. RASMUSSEN DD, BOLDT BM, WILKINSON CW et al. Daily melatonin administration at middle age suppresses male rat visceral fat, plasma leptin, and plasma insulin to youthful levels. Endocrinology 1999; 140:1009-1012.
17. TAN DX, MANCHESTER LC, FUENTES-BROTO L et al. Significance and application of melatonin in the regulation of brown adipose tissue metabolism: relation to human obesity. Obes Rev 2011; 12:167-188.
18. PROKOPENKO I, LANGENBERG C, FLOREZ JC et al. Variants in MTNR1B influence fasting glucose levels. Nat Genet 2009; 41:77-81.
19. LYSSENKO V, NAGORNY CLF, ERDOS MR et al. Common variant in MTNR1B associated with increased risk of type 2 diabetes and impaired early insulin secretion. Nat Genet 2009; 41:82-88.
20. BOUATIA-NAJI N, BONNEFOND A, CAVALCANTI-PROENCA C et al. A variant near MTNR1B is associated with increased fasting plasma glucose levels and type 2 diabetes risk. Nat Genet 2009; 41:89-94.
21. REILING E, VAN'T RIET E, GROENEWOUD MJ et al. Combined effects of single-nucleotide polymorphisms in GCK, GCKR, G6PC2 and MTNR1B on fasting plasma glucose and type 2 diabetes risk. Diabetologia 2009; 52:1866-1870.
22. ANHE GF, CAPERUTO LC, PEREIRA-DA-SILVA M et al. In vivo activation of insulin receptor tyrosine kinase by melatonin in the rat hypothalamus. J Neurochem 2004; 90:559-566.
23. ALONSO-VALLE MIC, ANDREOTTI S, BORGES-SILVA CN et al. Intermittent and rhythmic exposure to melatonin in primary cultured adipocytes enhances the insulin and dexamethasone effects on leptin expression. J Pineal Res 2006; 41:28-34.
24. ALONSO-VALE MIC, ANDREOTTI S, MUKAI PY et al. Melatonin and the circadian entrainment of metabolic and hormonal activities in primary isolated adipocytes. J Pineal Res 2008; 45:422-429.
25. ALONSO-VALE MIC, ANDREOTTI S, PERES SB et al. Melatonin enhances leptin expression by rat adipocytes in the presence of insulin. Am J Physiol Endocrinol Metab 2005; 288:E805-812.
26. LIMA FB, MACHADO UF, BARTOL I et al. Pinealectomy causes glucose intolerance and decreases adipose cell responsiveness to insulin in rats. Am J Physiol 1998; 275:E934-941.
27. PICINATO MC, HABER EP, CARPINELLI AR et al. Daily rhythm of glucose-induced insulin secretion by isolated islets from intact and pinealectomized rat. J Pineal Res 2002; 33:172-177.
28. PICINATO MC, HABER EP, CIPOLLA-NETO J et al. Melatonin inhibits insulin secretion and decreases PKA levels without interfering with glucose metabolism in rat pancreatic islets. J Pineal Res 2002; 33:156-160.
29. GHOSH G, DE K, MAITY S et al. Melatonin protects against oxidative damage and restores expression of GLUT4 gene in the hyperthyroid rat heart. J Pineal Res 2007; 42:71-82.
30. PELICIARI-GARCIA RA, MARCAL AC, SILVA JA et al. Insulin temporal sensitivity and its signaling pathway in the rat pineal gland. Life Sci 2010; 87:169-174.
31. BONORA E, MOGHETTI P, ZANCANARO C et al. Estimates of in vivo insulin action in man: comparison of insulin tolerance tests with euglycemic and hyperglycemic glucose clamp studies. J Clin Endocrinol Metab 1989; 68:374-378.
32. BRADFORD MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72:248-254.
33. ROMERO-CALVO I, OCON B, MARTINEZ-MOYA P et al. Reversible Ponceau staining as a loading control alternative to actin in Western blots. Anal Biochem 2010; 401:318-320.
34. POPOVICH IG, ZABEZHINSKI MA, EGORMIN PA et al. Insulin in aging and cancer: antidiabetic drug Diabenol as geroprotector and anticarcinogen. Int J Biochem Cell Biol 2005; 37:1117-1129.
35. NISHIMURA H, KUZUYA H, OKAMOTO M et al. Change of insulin action with aging in conscious rats determined by euglycemic clamp. Am J Physiol 1988; 254:E92-98.
36. WATVE MG, YAJNIK CS. Evolutionary origins of insulin resistance: a behavioral switch hypothesis. BMC Evol Biol 2007; 7:61.
37. HUANG C, THIRONE ACP, HUANG X et al. Differential contribution of insulin receptor substrates 1 versus 2 to insulin signaling and glucose uptake in l6 myotubes. J Biol Chem 2005; 280:19426-19435.
38. RASMUSSEN DD, MITTON DR, LARSEN SA et al. Aging-dependent changes in the effect of daily melatonin supplementation on rat metabolic and behavioral responses. J Pineal Res 2001; 31:89-94.
39. GARCIA RAP, AFECHE SC, SCIALFA JH et al. Insulin modulates norepinephrine-mediated melatonin synthesis in cultured rat pineal gland. Life Sci 2008; 82:108-114.
40. ZANQUETTA MM, SERAPHIM PM, SUMIDA DH et al. Calorie restriction reduces pinealectomy-induced insulin resistance by improving GLUT4 gene expression and its translocation to the plasma membrane. J Pineal Res 2003; 35:141-148.
41. GUO T, JOU W, CHANTURIYA T et al. Myostatin inhibition in muscle, but not adipose tissue, decreases fat mass and improves insulin sensitivity. PLoS ONE 2009; 4:e4937.
42. SOLOMON TPJ, SISTRUN SN, KRISHNAN RK et al. Exercise and diet enhance fat oxidation and reduce insulin resistance in older obese adults. J Appl Physiol 2008; 104:1313-1319.
43. AGIL A, NAVARRO-ALARCON M, RUIZ R et al. Beneficial effects of melatonin on obesity and lipid profile in young Zucker diabetic fatty rats. J Pineal Res 2011; 50:207-212.
44. RASKIND MA, BURKE BL, CRITES NJ et al. Olanzapineinduced weight gain and increased visceral adiposity is blocked by melatonin replacement therapy in rats. Neuropsychopharmacology 2007; 32:284-288.
45. HAVRANKOVA J, SCHMECHEL D, ROTH J et al. Identification of insulin in rat brain. Proc Natl Acad Sci USA 1978; 75:5737-5741.
46. BASKIN DG, FIGLEWICZ DP, WOODS SC et al. Insulin in the brain. Annu Rev Physiol 1987; 49:335-347.
47. COPPOLA A, DIANO S. Hormonal regulation of the arcuate nucleus melanocortin system. Front Biosci 2007; 12:3519-3530.
48. FROLICH L, BLUM-DEGEN D, RIEDERER P et al. A disturbance in the neuronal insulin receptor signal transduction in sporadic Alzheimer's disease. Ann N Y Acad Sci 1999; 893:290-293.
49. GARCIA-SAN FRUTOS M, FERNANDEZ-AGULLO T, DE SOLIS AJ et al. Impaired central insulin response in aged Wistar rats: role of adiposity. Endocrinology 2007; 148:5238-5247.
50. SERRANO R, VILLAR M, GALLARDO N et al. The effect of aging on insulin signalling pathway is tissue dependent: central role of adipose tissue in the insulin resistance of aging. Mech Ageing Dev 2009; 130:189-197.
51. RUIZ P, PULIDO JA, MARTINEZ C et al. Effect of aging on the kinetic characteristics of the insulin receptor autophosphorylation in rat adipocytes. Arch Biochem Biophys 1992; 296:231-238.
52. CARRASCOSA JM, RUIZ P, MARTINEZ C et al. Insulin receptor kinase activity in rat adipocytes is decreased during aging. Biochem Biophys Res Commun 1989; 160:303-309
53. ESCRIVA F, GAVETE ML, FERMIN Y et al. Effect of age and moderate food restriction on insulin sensitivity in Wistar rats: role of adiposity. J Endocrinol 2007; 194:131-141.
54. SMITH U. Impaired ('diabetic') insulin signaling and action occur in fat cells long before glucose intolerance-is insulin resistance initiated in the adipose tissue? Int J Obes Relat Metab Disord 2002; 26:897-904.
55. ABEL ED, PERONI O, KIM JK et al. Adipose-selective targeting of the GLUT4 gene impairs insulin action in muscle and liver. Nature 2001; 409:729-733.
56. BLUHER M, MICHAEL MD, PERONI OD et al. Adipose tissue selective insulin receptor knockout protects against obesity and obesity-related glucose intolerance. Dev Cell 2002; 3:25-38
57. FASSHAUER M, KLEIN J, UEKI K et al. Essential role of insulin receptor substrate-2 in insulin stimulation of Glut4 translocation and glucose uptake in brown adipocytes. J Biol Chem 2000; 275:25494-25501.
58. KABURAGI Y, SATOH S, TAMEMOTO H et al. Role of insulin receptor substrate-1 and pp 60 in the regulation of insulininduced glucose transport and GLUT4 translocation in primary adipocytes. J Biol Chem 1997; 272:25839-25844.
59. QUON MJ, BUTTE AJ, ZARNOWSKI MJ et al. Insulin receptor substrate 1 mediates the stimulatory effect of insulin on GLUT4 translocation in transfected rat adipose cells. J Biol Chem 1994; 269:27920-27924.
60. ROSE DW, SALTIEL AR, MAJUMDAR M et al. Insulin receptor substrate 1 is required for insulin-mediated mitogenic signal transduction. Proc Natl Acad Sci USA 1994; 91:797-801.
61. DUAN C, YANG H, WHITE MF et al. Disruption of the SH2-B gene causes age-dependent insulin resistance and glucose intolerance. Mol Cell Biol 2004; 24:7435-7443.
62. KAWASAKI N, ASADA R, SAITO A et al. Obesity-induced endoplasmic reticulum stress causes chronic inflammation in adipose tissue. Sci Rep 2012; 2:799.
63. NISHIDA S. Metabolic effects of melatonin on oxidative stress and diabetes mellitus. Endocrine 2005; 27:131-136.
64. PADILLO FJ, CRUZ A, NAVARRETE C et al. Melatonin prevents oxidative stress and hepatocyte cell death induced by experimental cholestasis. Free Radic Res 2004; 38:697-704.
65. PAGLIASSOTTI M, HORTON T. Hormonal and neural regulation of hepatic glucose uptake. In: The Role of the Liver in Maintaining Glucose Homeostasis (Medical Intelligence Unit), PAGLIASSOTTI MJ, DAVIS SN, CHERRINGTON AD, eds., R G Landes Co, Austin, 1994; pp. 45-70.
66. TANIGUCHI CM, UEKI K, KAHN R. Complementary roles of IRS-1 and IRS-2 in the hepatic regulation of metabolism. J Clin Invest 2005; 115:718-727.
67. LOGIE L, RUIZ-ALCARAZ AJ, KEANE M et al. Characterization of a protein kinase B inhibitor in vitro and in insulin-treated liver cells. Diabetes 2007; 56:2218-2227.
68. NOGUEIRA TC, LELLIS-SANTOS C, JESUS DS et al. Absence of melatonin induces night-time hepatic insulin resistance and increased gluconeogenesis due to stimulation of nocturnal unfolded protein response. Endocrinology 2011; 152:1253-1263.
69. ESCRIVA F, AGOTE M, RUBIO E et al. In vivo insulin-dependent glucose uptake of specific tissues is decreased during aging of mature Wistar rats. Endocrinology 1997; 138:49-54.
70. CLEASBY ME, REINTEN TA, COONEY GJ et al. Functional studies of Akt isoform specificity in skeletal muscle in vivo; maintained insulin sensitivity despite reduced insulin receptor substrate-1 expression. Mol Endocrinol 2007; 21:215-228.
71. SERAPHIM PM, NUNES MT, MACHADO UF. GLUT4 protein expression in obese and lean 12-month-old rats: insights from different types of data analysis. Braz J Med Biol Res 2001; 34:1353-1362.